Bexxar highly effective as first-line treatment for patients with non-Hodgkin's lymphoma

Study shows radioactive antibodies produce durable remissions of three years or more

NEW ORLEANS - A radioactive antibody compound known as Bexxar produced tumor shrinkage in 97 percent of 76 previously untreated patients with advanced-stage, low-grade non-Hodgkins lymphoma (NHL) in a new study at the University of Michigan Comprehensive Cancer Center.

Most notably, 76 percent of patients achieved a complete remission, with no sign of cancer. In addition, 84 percent of patients with evidence of lymphoma at the molecular level at the start of the trial achieved molecular remission for as long as three years with the treatment. Molecular remissions were determined by a rigorous use of polymerase chain reaction, or PCR, technology, arguably the most sensitive cancer detection method available today.

These promising results, from the first completed study of a first-line, stand-alone radioimmunotherapy for cancer, were presented today at the meeting of the American Society of Clinical Oncology by Mark S. Kaminski, M.D., U-M professor of hematology/oncology and co-director of the U-M's leukemia/lymphoma and bone marrow transplant programs.

The original studies in the therapeutic development of Bexxar, or Iodine I 131 tositumomab, were done at the U-M by Kaminski and his colleague Richard Wahl, M.D., professor of nuclear medicine and radiology. The therapy is now being jointly developed by Coulter Pharmaceutical, Inc. and SmithKline Beecham.

"We are extremely excited by these findings, which showed remarkable response rates and molecular remissions lasting up to and beyond three years," says Kaminski. "Molecular remissions are seldom seen with chemotherapy in low-grade lymphoma, and appear to coincide with prolonged, durable responses. Furthermore, these results demonstrate the potential of this treatment as an effective and well-tolerated first-line, single-agent treatment for low-grade lymphoma, a disease without a known cure."


Contact: Kara Gavin
University of Michigan Health System

Page: 1 2 3

Related medicine news :

1. New highly active agents against sandfly fever
2. Engineers develop biowarfare sensing elements for future highly sensitive nerve-gas detectors
3. Patients with cancer have highly increased risk for blood clots
4. Inflammatory cells highly promising target in NF 1
5. Multi-center study finds therapy boosts kidney transplants in highly sensitized patients
6. Columbia Univ. Medical Center wins highly competitive stroke grant from NIH
7. Study showed vitamin D inadequacy highly prevalent among women treated for osteoporosis
8. World mental health surveys find mental disorders highly prevalent and often untreated
9. MRI highly useful in the evaluation of patients with uterine fibroids
10. 1st data show CRESTOR highly effective at lowering LDL-C in patients with type 2 diabetes
11. One in five asthmatics are highly sensitive to aspirin

Post Your Comments:

(Date:9/3/2020)... , ... September 03, 2020 , ... ... is sponsoring the American Foundation for Suicide Prevention’s (AFSP) annual signature event, Out ... people across hundreds of U.S. cities to raise awareness of suicide prevention. To ...
(Date:9/3/2020)... ... September 03, 2020 , ... MemoryCare.com, a comprehensive ... Best Memory Care Facilities in Louisville, KY. The guide identifies 17 memory care ... According to the Alzheimer’s Association , 5.6 million people age 65 and ...
(Date:9/1/2020)... ... September 01, 2020 , ... Board certified plastic ... While the office will be the first to bear her name, Dr. Saber ... (Brazilian butt lift), as well as rhinoplasty, facial rejuvenation, and many more in ...
(Date:9/1/2020)... ... ... As fall and winter swiftly approach and many businesses cut costs to ... time to expand and grow into a full-fledged natural health clinic over the past ... relaunching its brand new website, expanding its services menu and has recruited top-tier healthcare ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... the 10th Anniversary of Blood Cancer Awareness Month (BCAM) and its international ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... ... 27, 2020 , ... Trella Health, the leading source of ... cloud CRM, marketing automation, and contact center solutions for senior living communities and ... Trella’s performance intelligence data and insights into Enquire’s CRM solution to serve as ...
(Date:8/26/2020)... ... August 26, 2020 , ... ... Eurofins BioPharma Services, Laboratory Testing division, expands its technology footprint with the ... Flow Cytometry platforms available. With industry-leading biomarker solutions, complemented with traditional ligand-binding ...
(Date:8/26/2020)... ... August 26, 2020 , ... Hero Life Sciences ... goal of 115 million 3 ply surgical disposable face masks and N95 respirators in ... direct response to the challenge that most Americans are facing in trying to find ...
Breaking Medicine Technology:
Cached News: